TRI-AAT9-1 |
|
tRNA-Ile (anticodon AAT) 9-1
|
|
|
0.821 |
0.192 |
MIR3149 |
|
microRNA 3149
|
|
|
0.839 |
0.192 |
VNN3 |
Q9NY84
|
vanin 3
|
Enzyme
|
4.3E-03 |
0.821 |
0.269 |
MIR208B |
|
microRNA 208b
|
|
|
0.700 |
0.308 |
NDUFC2 |
O95298
|
NADH:ubiquinone oxidoreductase subunit C2
|
Enzyme
|
0.68 |
0.805 |
0.308 |
PEAR1 |
Q5VY43
|
platelet endothelial aggregation receptor 1
|
|
3.5E-20 |
0.722 |
0.346 |
GALNT4 |
Q8N4A0
|
polypeptide N-acetylgalactosaminyltransferase 4
|
|
0.27 |
0.736 |
0.346 |
PRKAR1B |
P31321
|
protein kinase cAMP-dependent type I regulatory subunit beta
|
|
0.18 |
0.716 |
0.385 |
TRS-AGA2-3 |
|
tRNA-Ser (anticodon AGA) 2-3
|
|
|
0.743 |
0.385 |
MARCHF9 |
Q86YJ5
|
membrane associated ring-CH-type finger 9
|
|
0.73 |
0.743 |
0.385 |
TNNT2 |
P45379
|
troponin T2, cardiac type
|
Cellular structure
|
2.0E-03 |
0.601 |
0.423 |
CCS |
O14618
|
copper chaperone for superoxide dismutase
|
Enzyme
|
8.6E-08 |
0.628 |
0.423 |
MIR605 |
|
microRNA 605
|
|
|
0.644 |
0.423 |
HDL3 |
|
Huntington-like neurodegenerative disorder 2
|
|
|
0.663 |
0.423 |
NANOS1 |
Q8WY41
|
nanos C2HC-type zinc finger 1
|
|
0.54 |
0.700 |
0.423 |
ELOVL2 |
Q9NXB9
|
ELOVL fatty acid elongase 2
|
Enzyme
|
8.4E-10 |
0.722 |
0.423 |
CKM |
P06732
|
creatine kinase, M-type
|
Kinase
|
7.8E-03 |
0.743 |
0.423 |
MARCHF7 |
Q9H992
|
membrane associated ring-CH-type finger 7
|
|
0.66 |
0.705 |
0.462 |
JUP |
P14923
|
junction plakoglobin
|
|
8.0E-04 |
0.628 |
0.500 |
ATP8B1 |
O43520
|
ATPase phospholipid transporting 8B1
|
Transporter
|
2.8E-10 |
0.610 |
0.500 |
ADAMTS10 |
Q9H324
|
ADAM metallopeptidase with thrombospondin type 1 motif 10
|
Enzyme
|
0.84 |
0.641 |
0.500 |
ACSL5 |
Q9ULC5
|
acyl-CoA synthetase long chain family member 5
|
Enzyme
|
2.9E-09 |
0.641 |
0.500 |
KCNE5 |
Q9UJ90
|
potassium voltage-gated channel subfamily E regulatory subunit 5
|
|
0.12 |
0.666 |
0.500 |
NRDC |
O43847
|
nardilysin convertase
|
Enzyme
|
4.4E-02 |
0.647 |
0.500 |
NBL1 |
P41271
|
NBL1, DAN family BMP antagonist
|
|
5.9E-02 |
0.670 |
0.500 |